Total Payments
$28,890
2018 Payments
$18,547
Companies
2
Transactions
51
Payment Breakdown by Category
Other$24,130 (83.5%)
Travel$3,343 (11.6%)
Food & Beverage$1,363 (4.7%)
Education$53.98 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,130 | 14 | 83.5% |
| Travel and Lodging | $3,343 | 16 | 11.6% |
| Food and Beverage | $1,363 | 19 | 4.7% |
| Education | $53.98 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $15,841 | 23 | $0 (2018) |
| Astellas Pharma US Inc | $13,049 | 28 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $18,547 | 33 | Merck Sharp & Dohme Corporation ($11,474) |
| 2017 | $10,342 | 18 | Astellas Pharma US Inc ($5,975) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $71.78 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/01/2018 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $215.00 | General |
| 10/30/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/30/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/25/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/27/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/27/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/24/2018 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $215.00 | General |
| 08/22/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Travel and Lodging | In-kind items and services | $514.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/22/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Travel and Lodging | In-kind items and services | $321.10 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/16/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $28.99 | General |
| 07/02/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/02/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/27/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $478.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/27/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $418.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/27/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/25/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/24/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/14/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/14/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/09/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $435.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/09/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $432.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/09/2018 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. James Ito, MD
Dr. James Ito, MD is a Internal Medicine healthcare provider based in La Verne, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427165463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Ito, MD has received a total of $28,890 in payments from pharmaceutical and medical device companies, with $18,547 received in 2018. These payments were reported across 51 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,130).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location La Verne, CA
- Active Since 08/24/2006
- Last Updated 08/07/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427165463
Products in Payments
- PREVYMIS (Drug) $8,488
- NOXAFIL (Drug) $7,353
- CRESEMBA (Drug) $6,591
- Cresemba (Drug) $5,950
- MYCAMINE (Drug) $23.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in La Verne
Dr. Tan Wong, Md, MD
Internal Medicine — Payments: $31,018
Internal Medicine $31,018
Mr. Sadiq Mandilawi, Md, MD
Internal Medicine — Payments: $4,856
Internal Medicine $4,856
Mr. Younis Ali, Md, MD
Internal Medicine — Payments: $496.63
Internal Medicine $496.63
Dr. Eduardo Siccion, Md, MD
Internal Medicine — Payments: $419.34
Internal Medicine $419.34
Dr. Mara Archambault, Md, MD
Internal Medicine — Payments: $149.43
Internal Medicine $149.43
Dr. Freddie Ibrahim, M.d, M.D
Internal Medicine
Internal Medicine